- Advanced HR+, HER2- Breast Cancer
- About AFINITOR
- M.O.R.E. Support
- Important Safety Information
APPROVED TREATMENT for Advanced HR+, HER2- Breast Cancer
AFINITOR is a prescription medicine used to treat advanced hormone receptor-positive,
HER2-negative breast cancer, along with the medicine exemestane, in postmenopausal women who have already received certain other medicines for their cancer.
Important Safety Information
AFINITOR can cause serious side effects, including lung or breathing problems, infections, and kidney failure, which can lead to death. Mouth ulcers and mouth sores are common side effects, occurring in up to 86% of patients taking AFINITOR. AFINITOR can affect blood cell counts, kidney and liver function, and blood sugar and cholesterol levels. Regular blood tests should be performed before starting AFINITOR and as needed during treatment to check blood cell count, kidney and liver function, and blood sugar and cholesterol levels.
Please see additional Important Safety Information.
Please see full Prescribing Information.